These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 9669503

  • 1. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
    Liao CH, Tzeng CC, Teng CM.
    Eur J Pharmacol; 1998 May 15; 349(1):107-14. PubMed ID: 9669503
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.
    Wu CC, Wang WY, Kuo RY, Chang FR, Wu YC.
    Eur J Pharmacol; 2004 Jan 12; 483(2-3):187-94. PubMed ID: 14729106
    [Abstract] [Full Text] [Related]

  • 3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM.
    Br J Pharmacol; 1995 Oct 12; 116(3):1973-8. PubMed ID: 8640334
    [Abstract] [Full Text] [Related]

  • 4. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH, Haslam RJ.
    Mol Pharmacol; 1990 May 15; 37(5):671-81. PubMed ID: 2160060
    [Abstract] [Full Text] [Related]

  • 6. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM.
    Blood; 1994 Dec 15; 84(12):4226-33. PubMed ID: 7527671
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC, Huang WH, Shiau CY, Lee AR, Chou TC.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):32-7. PubMed ID: 16457809
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of inhibition of platelet aggregation by HCL-31D.
    Chou TC, Li CY, Lee AR, Wu TM.
    Eur J Pharmacol; 2000 Jan 10; 387(2):125-31. PubMed ID: 10650152
    [Abstract] [Full Text] [Related]

  • 9. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M, Endo T, Kanayama T, Hidaka H.
    J Pharmacol Exp Ther; 1984 Feb 10; 228(2):467-71. PubMed ID: 6141286
    [Abstract] [Full Text] [Related]

  • 10. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ.
    Biochim Biophys Acta; 1976 Sep 24; 444(2):579-95. PubMed ID: 9149
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH, Ko FN, Wu CL, Teng CM.
    J Pharm Pharmacol; 2000 Mar 24; 52(3):353-9. PubMed ID: 10757426
    [Abstract] [Full Text] [Related]

  • 12. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
    Matsuoka I, Suzuki T.
    J Cyclic Nucleotide Protein Phosphor Res; 1983 Mar 24; 9(4-5):341-53. PubMed ID: 6147364
    [Abstract] [Full Text] [Related]

  • 13. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM, Chen CC, Ko FN, Huang YL, Huang TF, Teng CM.
    Biochem Pharmacol; 1992 Jan 22; 43(2):323-9. PubMed ID: 1310852
    [Abstract] [Full Text] [Related]

  • 14. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
    Hirose R, Okumura H, Yoshimatsu A, Irie J, Onoda Y, Nomoto Y, Takai H, Ohno T, Ichimura M.
    Eur J Pharmacol; 2001 Nov 09; 431(1):17-24. PubMed ID: 11716838
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH, Ko FN, Kuo YH, Teng CM.
    Can J Physiol Pharmacol; 1996 Oct 09; 74(10):1111-6. PubMed ID: 9022830
    [Abstract] [Full Text] [Related]

  • 16. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM, Kuo SC.
    Br J Pharmacol; 1995 Apr 09; 114(8):1587-94. PubMed ID: 7599926
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
    Azuma H, Takashima Y, Ishikawa M, Yamakado T.
    Jpn J Pharmacol; 1984 Feb 09; 34(2):159-70. PubMed ID: 6205194
    [Abstract] [Full Text] [Related]

  • 18. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
    Liao CH, Ko FN, Kuo SC, Teng CM.
    Jpn J Pharmacol; 1998 Feb 09; 76(2):141-8. PubMed ID: 9541276
    [Abstract] [Full Text] [Related]

  • 19. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
    Hickie RA.
    Adv Exp Med Biol; 1998 Feb 09; 92():451-88. PubMed ID: 24988
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin.
    Chou TC, Lin YF, Wu WC, Chu KM.
    Br J Pharmacol; 2008 Mar 09; 153(6):1281-7. PubMed ID: 18264124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.